businesspress24.com - Kadmon Corporation to Present at Two Upcoming Investor Conferences
 

Kadmon Corporation to Present at Two Upcoming Investor Conferences

ID: 1345399

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 03/19/15 -- Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present an overview of Kadmon and its clinical and commercial programs at two upcoming investor conferences:

-- 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference on Friday, March 20th at 9:00 a.m. ET at the Millennium Broadway Hotel in New York City

-- JMP Securities Life Sciences Private Company Conference on Friday, March 27th at 9:30 a.m. ET at Le Parker Meridien in New York City

A live audio webcast of the BioCentury presentation will be accessible at . The webcast will be archived for 12 months.

Kadmon Corporation, LLC, is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in autoimmune and fibrotic diseases, oncology, monogenic diseases and metabolic disease. For more information, visit .

This press release contains forward-looking statements. These forward-looking statements are based on management''s expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.



Ellen Tremaine
Investors
646.490.2989


David Pitts
Argot Partners
212.600.1902




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Flamel Technologies Announces Fourth Quarter and Full Year Results of Fiscal Year 2014
GSK and Theravance Announce Outcome of US FDA Advisory Committee on BREO(R) ELLIPTA(R) in Asthma
Bereitgestellt von Benutzer: Marketwired
Datum: 19.03.2015 - 08:30 Uhr
Sprache: Deutsch
News-ID 1345399
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 142 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at Two Upcoming Investor Conferences
"
steht unter der journalistisch-redaktionellen Verantwortung von

Kadmon Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Kadmon Corporation



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 82


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.